Home

Jean Jacques Bienaime, Director: Keros Therapeutics KROS Buy · Filed 03/11

Trade details

Type
Insider buy
Amount
$22,420
Shares · price
2,000 sh · $11.21 a share
Held after
7,450 sh
Trade date
26/03/09
Filed
26/03/11
Days to filing
2 days

First buy since 2023

Insiders buying this week
1 insiders
Holding change
+36.7%

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 02/07~04/08

Jean Jacques Bienaime's recent trades